Renal cell carcinoma with succinate dehydrogenase A mutation: A case report and literature review

Min Hu1, Xiao-Tong Wang2, Xue-Xue Xiao1

  • 1Department of Pathology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China.

Oncology Letters
|December 12, 2024
PubMed

Insights

Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is rare. This study details a novel SDHA gene mutation in a young female patient, expanding knowledge of SDH-deficient RCC.

Area of Science:

  • Oncology
  • Genetics

Background:

  • Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a rare subtype characterized by germline mutations in SDH enzyme subunits.
  • Loss of SDH function, crucial for cellular respiration, results from these mutations combined with a somatic second hit.

Observation:

  • This report describes a 22-year-old female patient diagnosed with RCC associated with a germline SDHA gene mutation.
  • Genetic analysis revealed a novel heterozygous frameshift variant (c.992_999dup) in the SDHA gene, previously unreported in RCC.

Findings:

  • The identified SDHA mutation is novel and has not been previously linked to renal cell carcinoma in existing literature.
  • This case represents one of the few documented instances of SDH-deficient RCC specifically associated with an SDHA mutation.

Implications:

  • The findings expand the known phenotypic spectrum associated with SDHA gene variants.
  • This case provides valuable clinical, morphological, and molecular data for understanding SDH-deficient RCC and its genetic basis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K